X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
Growth Equity Opportunities 18 VGE, LLC reported a 9.99% stake in X4 Pharmaceuticals, Inc. (Schedule 13D/A)
Event Aug 13, 2025 · Filed Aug 15, 2025
Growth Equity Opportunities 18 VGE, LLC reported a 9.99% stake in X4 Pharmaceuticals, Inc., 2,243,658 shares, with active intent on Aug 13, 2025. Filed Aug 15, 2025 (Schedule 13D/A).
- Stake
- 9.99%
- Shares
- 2,243,658
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 12 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Growth Equity Opportunities 18 VGE, LLC | 9.99% | 2,243,658 |
| NEA 18 Venture Growth Equity, L.P. | 9.99% | 2,243,658 |
| NEA Partners 18 VGE, L.P. | 9.99% | 2,243,658 |
| NEA 18 VGE GP, LLC | 9.99% | 2,243,658 |
| Ali Behbahani | 9.99% | 2,243,658 |
| Carmen Chang | 9.99% | 2,243,658 |
| Anthony A. Florence, Jr. | 9.99% | 2,243,658 |
| Mohamad H. Makhzoumi | 9.99% | 2,243,658 |
| Edward T. Mathers | 9.99% | 2,243,658 |
| Scott D. Sandell | 9.99% | 2,243,658 |
| Paul Walker | 9.99% | 2,243,658 |
| Rick Yang | 9.99% | 2,243,658 |
Source
Related
- X4 Pharmaceuticals, Inc.
- Growth Equity Opportunities 18 VGE, LLC
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13D/A · Growth Equity Opportunities 18 VGE, LLC · Oct 29, 2025
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026